Actively Recruiting
A Trial of Three- and Seven-days Insulin Infusions Set
Led by Steno Diabetes Center Copenhagen · Updated on 2024-08-06
80
Participants Needed
1
Research Sites
127 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
More and more children and adolescents are using diabetes devices attached to the skin. The attachment of infusions sets to the skin provoke allergenic or toxic eczema, the continous infusion of insulin provoke subcutaneous changes and prolonged wear time seems to increase the risk of these complication. On the other site fewer skin stripping episodes with longer wear time and filtration of the insulin may be beneficial for the skin, therefore comparing the occurrence of subcutaneous hyper echogenicity, eczema and the skin barrier in users of 3 and 7 days infusions set is highly relevant. The primary aim of present study is to investigate if the use of three days insulin infusion set is superior to seven days in preventing the occurrence of hyperechogenicity in areas recently used for insulin infusion and if the type of insulin matter comparing insulin aspart - Novo Rapid, or insulin lispro - Humalog
CONDITIONS
Official Title
A Trial of Three- and Seven-days Insulin Infusions Set
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Type 1 Diabetes
- Diabetes duration of more than 6 months prior to inclusion
- Currently using the Medtronic 780G pump and sensor with automated insulin delivery or planning to use it
- Aged between 7 and 18 years before inclusion
- Insulin needs over 8 units per day
You will not qualify if you...
- Unable to read and understand Danish
- Cognitive impairments that affect answering questionnaires or participating in phone or video calls
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Steno Diabetes Center Copenhagen
Herlev, Capital, Denmark, 2730
Actively Recruiting
Research Team
J
Jannet Svensson, Professor
CONTACT
J
Julian Bjerrekær, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here